Celadon Pharmaceuticals Plc announced last week that it has been approved to commence a unique non-cancer chronic pain clinical trial for up to 5,000...
A recent survey suggests 18.6% of caregivers looking after an autistic child are administering cannabidiol (CBD).Autism Parenting Magazine's survey sent out to more than...
Initial conclusions of the combined first and second cohorts of a US cannabidiol industry-sponsored liver safety study has indicated a good safety profile for...